Anti-PD-L1 monotherapy increased intra-tumor immune cell infiltration of all cell subsets analyzed, with statistically significant changes in CD3+ T cell, CD4+ T cell, and natural killer (NK) cells. The gene discussed is CD4; the disease is neoplasm.